The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction

Harry H. Yoon; Val J. Lowe; Stephen D. Cassivi; Yvonne Romero

doi:10.1016/j.gtc.2009.01.007

The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction

Harry H. Yoon, Val J. Lowe, Stephen D. Cassivi, Yvonne Romero

Research output: Contribution to journal › Review article › peer-review

8 Scopus citations

Abstract

The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[¹⁸F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.

Original language	English (US)
Pages (from-to)	105-120
Number of pages	16
Journal	Gastroenterology Clinics of North America
Volume	38
Issue number	1
DOIs	https://doi.org/10.1016/j.gtc.2009.01.007
State	Published - Mar 2009

Keywords

CT
Esophageal cancer
Gastroesophageal junction cancer
PET
Prognosis
Staging
Staging laparoscopy
Treatment response

ASJC Scopus subject areas

Gastroenterology

Access to Document

10.1016/j.gtc.2009.01.007

Cite this

@article{1f3e4e3e0f8948a5b166aa2a8b64e5a7,

title = "The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction",

abstract = "The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[18F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.",

keywords = "CT, Esophageal cancer, Gastroesophageal junction cancer, PET, Prognosis, Staging, Staging laparoscopy, Treatment response",

author = "Yoon, {Harry H.} and Lowe, {Val J.} and Cassivi, {Stephen D.} and Yvonne Romero",

year = "2009",

month = mar,

doi = "10.1016/j.gtc.2009.01.007",

language = "English (US)",

volume = "38",

pages = "105--120",

journal = "Gastroenterology Clinics of North America",

issn = "0889-8553",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction

AU - Yoon, Harry H.

AU - Lowe, Val J.

AU - Cassivi, Stephen D.

AU - Romero, Yvonne

PY - 2009/3

Y1 - 2009/3

N2 - The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[18F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.

AB - The effort to improve outcomes in esophageal cancer has included attempts at improving staging and patient selection. 2-Deoxy-2-[18F]fluoro-Dglucose positron emission tomography (FDG-PET) has been extensively studied in this context and has been widely accepted as a staging tool. Its role in restaging or assessing therapeutic response is investigational and promising. Laparoscopy has also been studied as a means for improving staging, but its role may be limited in the era of PET. This article discusses the literature assessing these modalities, particularly with regard to the practical management of the patient in the clinic.

KW - CT

KW - Esophageal cancer

KW - Gastroesophageal junction cancer

KW - PET

KW - Prognosis

KW - Staging

KW - Staging laparoscopy

KW - Treatment response

UR - http://www.scopus.com/inward/record.url?scp=62749194562&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62749194562&partnerID=8YFLogxK

U2 - 10.1016/j.gtc.2009.01.007

DO - 10.1016/j.gtc.2009.01.007

M3 - Review article

C2 - 19327570

AN - SCOPUS:62749194562

SN - 0889-8553

VL - 38

SP - 105

EP - 120

JO - Gastroenterology Clinics of North America

JF - Gastroenterology Clinics of North America

IS - 1

ER -

The Role of FDG-PET and Staging Laparoscopy in the Management of Patients with Cancer of the Esophagus or Gastroesophageal Junction

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this